Global continuous renal replacement therapy market is anticipated to exceed USD 1.4 billion by the year 2025, according to the latest research available at Market Study Report, report provides extensively data on market share, growth, trends and forecasts for the period 2019-2025.
 

Increase in occurrence of diabetes across the globe will augment the market growth in the upcoming years. Diabetes damages the blood vessels in kidney causing disorders, which are even more prominent in the case of type 2 diabetes. These patients prominently rely on continuous renal replacement therapy (CRRT), thereby augmenting the market growth. Another factor driving the CRRT market is the growing geriatric population that is vulnerable to diabetes and renal failures.
 

Based on the modality, continuous venovenous hemodialysis (CVVHD) segment was worth USD 410 million in 2018 and is expected to witness a significant growth over the forecast period, as it is an effective treatment for patients suffering from acute renal failure. The treatment is preferable for geriatric patients and has various technical advantages.
 

Considering the product type, CRRT market from consumables segment is predicted to witness more than 7.0% growth over the analysis timeline. Consumables used in the therapy are of superior quality and cost-effective. The need for periodic replacement of these consumable to prevent contamination will boost the segmental growth.
 

On the basis of therapy type, the non-renal CRRT market was worth USD 180 million in 2018 and is anticipated to grow significantly over the analysis timeframe. The therapy is applicable for non-renal ailments such as sepsis and inflammatory syndromes.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1357095/
 

In terms of geographical landscape, Europe continuous renal replacement therapy market is expected to grow with a CAGR of 6% over the forecast period. Rising instances of diabetes, along with the increase in number of baby boomers that are prone to chronic diseases will contribute towards the regional market growth.
 

Some of the notable eminent players in the continuous renal replacement therapy market are B.Braun Melsungen, Medical Components, Asahi Kasei Corporation, Nxtstage, Infomed, NikkisoToray, Fresenius Medical Care, Medtronic, Medites, Medica, and Baxter International.